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Abstract
Survival competing risks models are very useful for studying the incidence of diseases
whose occurrence competes with other possible diseases or health conditions. These mod-
els perform properly when working with terminal events, such as death, that imply the
conclusion of the corresponding study. But they do not allow the treatment of scenarios
with non-terminal competing events that may occur sequentially. Multi-state models are
complex survival models. They focus on pathways defined by the temporal and sequential
occurrence of numerous events of interest and thus they are suitable for connecting com-
peting non-terminal events as well as to manage other survival scenarios with higher com-
plexity. We discuss competing risks within the framework of multi-state models and clarify
the usefulness of both models for analysing epidemiological data. We highlight the power
of multi-state models through a real-world study of recurrent hip fracture from Bayesian
inferential methodology.
Key words: Bayesian inference, cause-specific hazard models, cumulative incidence function,
epidemiological data, illness-death models, transition probabilities.
Key messages
• We define the competing risks model as a particularization of the illness-death model, in
which no transition from illness to death is allowed.
• Both formulated models provide almost identical estimations of the cumulative incidences
for the competing events.
• We propose multi-state models as a preferable tool to estimate those incidences as they also
























1 Survival and event history analysis
Epidemiology deals with the incidence and evolution of diseases in populations. Although epi-
demiological studies can be conducted with different objectives and perspectives, time in these
projects is an important, and often essential, element. Survival and event history analysis also
address time and constitute important methodological tools for the treatment of epidemiolog-
ical data. They focus on time to the occurrence of one or several events of interest which, in
epidemiological research, are usually associated with death, the cure of a disease, a positive
and/or negative progression of a disease, the appearance of adverse effects, etc. as well as with
the possible trajectories determined by the occurrence of different events in individuals of the
target population.
Competing risk and multi-state models are particular survival models developed for the joint
statistical treatment of more than one event of interest (Putter et al., 2007). The first one deals
with survival times in the presence of competing events where the occurrence of a particular
event prevents the occurrence of all remaining events. Competing risks models are very useful
in medical and epidemiological research and have been widely used to assess rates and risks
(Lou et al., 2009; Andersen et al., 2012; Wei et al., 2018; Schuster et al., 2020).
There are different approaches for studying competing risk models. The two more popular
ones are the so-called multivariate time to failure model, which was the first model proposed
(Gail, 1975) in the survival literature, and the cause-specific hazards model subsequently in-
troduced by Gaynor (1993). We will focus on the latter because it does not have the problems of
lack of identifiability of the former and connects naturally and intuitively with the multi-state
framework. They allow to estimate the cumulative incidence of those events, i.e. the proportion
of individuals who would fail at any particular time, by means of modelling the hazard rate
associated to each event.
Multi-state models are complex models that focus on the complete event history. They are a
class of stochastic models that enable individuals to move between different states over time.
These states generally represent different conditions of illness and/or health. Relevant sur-
vival times are times between states which, from a methodological perspective, can be ana-
lyzed by means of stochastic processes and survival procedures (Andersen and Keiding, 2002).
Despite their enormous usefulness, multi-state models are not yet very popular in the world of
epidemiology (Commenges et al., 1999; Beyersmann et al., 2011; Hill et al., 2021).
Our aim in this paper is to establish connections between competing risks and multi-state
models that allow us to clarify the usefulness of both models for analysing data from epidemi-
ological settings as well as to deepen their analogies and differences. In particular, we want to
emphasise the potential of multi-state models to study epidemiological processes that require
the analysis of different health conditions whose occurrence may be sequential in time and
always in environments subject to uncertainty.
This paper is structured as follows: Section 2 reviews competing risks and multi-state mod-
els. In particular, Subsection 2.1 discusses the cause specific-hazard approach to competing
risk models, and Subsection 2.2 contains the main elements of multi-state models and de-
scribes in detail the so-called illness-death model, a particular type of multi-state models with
three states, two of them transient and one terminal. Subsection 2.3 examines the competing
risk models in the framework of multi-state models. Section 3 presents a study based on data
from the PREV2FO cohort, which comprises patients aged 65 years and older who were dis-
charged after a hospitalization for osteoporotic hip fracture between 2008 and 2015. We use a
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competing risks model and a multi-state model to analyse the follow-up of these patients over
time with special interest in the occurrence of a subsequent hip fracture or death. Both models
were analyzed via Bayesian statistics. This approach allows to obtain posterior distributions
of the different quantities of interest such as the cumulative incidence of refracture or death in
the competing risks model, or the proportion of people who die or remain alive after a refracture
in the case of the multi-state models. The paper ends with some concluding remarks.
2 Competing risks versus illness-death survival models
2.1 Competing risks models
As stated before, competing risks models are survival statistical models which consider many
causes of failure. Individuals in the study are followed from a common initial point until the
ocurrence of the first of the events considered. Such occurrence precludes the observation of
the rest of events, acting as a censoring event.
We assume, without loss of generality, a competing risk model with an initial state, 1, and
two possible events of interest, 2 and 3 (See Figure 1). Let T1j be the time from the start point
(1) to event j = 2, 3. Consider T = min{T12, T13} the time to the occurrence of the first event




P (t ≤ T < t+ ∆t, δ = j | T ≥ t)
∆t
, t > 0, (1)
where δ represents the indicator of the cause of the failure in such a way that δ = j when
the observation is failed from cause j, and δ = 0 when the observation is censored for events




Figure 1: Competing risks model with two possible causes of failure.
The cumulative hazard function for cause j at time t can be defined from (1) as H1j(t) =∫ t
0 h1j(u)du. The overall survival function S(t) accounts for the probability of not failing from
any cause at time t and it is defined as





The cumulative incidence function for cause j at t (also known as crude cumulative incidence
function or subdistribution function) describes the probability of failing from cause j before
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time t and it is given by




This probability is not a proper distribution function because F1j(t) does not go to 1 when t
goes to ∞. In particular, it equals to the probability of failure from cause j, F1j(∞) = P (δ =
j). Cumulative incidence functions are very meaningful, as they can be interpreted as the
proportion of individuals who failed by cause j before time t. They are the main outcomes of
any competing risks analysis.
Cox proportional hazard models (Cox, 1972) introduce covariates on the cause-specific haz-
ard functions. In particular, the cause-specific hazard of cause j at time t for an individual of
the target population with covariates x is
h1j(t) = h0,1j(t) exp{β(1j)′x}, j = 2, 3, t > 0 (4)
where h0,1j(t) is the baseline cause-specific function of failure j and β(1j) is the vector of regres-
sion coefficients.
2.2 Multi-state models
Multi-state models account for different structures depending on the number of states and
how they relate to each other (Andersen and Keiding, 2002). We focus on a particular type of
multi-state model known as the illness-death or disability model. This is a multi-state model
with three states, which generally represent different conditions, usually health, illness and
death. A healthy person can go directly to suffering from a certain illness or die without having
suffered from that illness. But it is also possible that they die after having suffered from the
illness. We are now faced with two competitive events but one of them is of a transitory nature
and allows access to the terminal event, death (See Figure 2). This model makes possible to




Figure 2: Illness-death model with an initial state (1), a transient state for illness (2), and an
absorbing state such as death (3).
The methodological framework of multi-state models in survival analysis is initially analo-
gous to that of competing risks. In the case of the cause-specific hazards approach we focus on
the hazard function for the survival times from state 1 to 2, T12, from 1 to 3, T13 , and from 2 to
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3, T23 as follows:
h1j(t) = lim
P (t ≤ T1j < t+ ∆t | T1j ≥ t)
∆t∆t→0
, j = 2, 3
h23(t− t12|T12 = t12) = lim
P (t− t12 ≤ T23 < t− t12 + ∆t | T23 ≥ t− t12, T12 = t12)
∆t∆t→0
. (5)
In many real problems (e.g. those associated with relapses of cancer diseases) the behaviour
of T23 often depends on the characteristics of transition 1 to 2. This situation is reflected in the
hazard in (5) which depends on the time when “illness occur” (T12 = t12), as it represents the
hazard of dying after illness.
Multi-state models are also a particular class of stochastic processes so their analysis is
enriched with the procedures associated with this type of models. In this regard, transition
probabilities are conditional probabilities pij(s, t) defined as the probability of being at the state
j at time t given that the individual was in state i at s. In the case of illness-death models,
the relevant transition probabilities are p11(s, t), p22(s, t | t12), which assess the permanence
in states 1 and 2, respectively, p12(s, t) and p13(s, t) which quantify the transition to the illness
and the death state from the initial state, respectively and, p23(s, t | t12) for the transition from
the illness state to death. Probabilities p22(s, t | t12) and p23(s, t | t12) account for the transition
time t12 from the healthy to the illness state. Note that p33(s, t | t12) = 1 as death is a terminal
state.
In practice, transition probabilities are calculated through transition intensities. The spe-
cific linkage between transition probabilities and hazard functions is as follows (Armero et al.,
2016):


















p13(s, t) = 1− p11(s, t)− p12(s, t)
p23(s, t | t12) = 1− p22(s, t)
p33(s, t) = 1, (6)
It is important to mention that p11(s, t), the probability associated with the permanence at
the initial state (1) during the time interval [s, t], is also well defined for a competing risks
model, with the same interpretation.
2.3 Competing risks model as a multi-state model
A competing risk model can be considered as a multi-state model with two types of events:
an initial state and two states for the competing causes of failure which can be terminal and
without connection among them. The only transitions between states with probability not
zero are the two that start from the initial state to each of the other two states. Transition
probabilities between the states can also be expressed in terms of the subsequent transition
intensities as follows (Andersen and Keiding, 2010):
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(h12(x) + h13(x)) dx
}
h1j(u) du, j = 2, 3
p22(s, t) = p33(s, t) = 1. (7)
It is worth mentioning that the overall survival function S(t) defined in (2) within the com-
peting risk scenario is the transition probability that assesses the permanence of the process
in the initial state at time t, S(t) = p11(0, t). Moreover, the cumulative incidence function for
cause 2 and for cause 3, F12(t) and F13(t), in the competing risk framework are the transition
probabilities p12(0, t) and p13(0, t), respectively.
3 The PREV2FO study: Incidence of refracture and death after
an osteoporotic hip fracture.
3.1 Problem, objective and data
Hip fracture is a main complication of osteoporosis in elder populations. Beyond its economic
cost for health care systems and society, it results in significant reductions in quality of life,
disability, morbidity and mortality (Lips et al., 2005, Hopkins et al., 2016, Hernlund et al.,
2013). Patients after a hip fracture are at much higher risk of a subsequent hip fracture
(Johnell et al. 2004, Ryg et al. 2009) as well as death, and excess of mortality is even higher
after a second hip fracture (Abrahamsen et al., 2009, Sobolev et al., 2015).
For the case study we used the PREV2FO cohort, a population-based cohort of all patients
aged 65 years and older, discharged alive after hospitalization for osteoporotic hip fracture
from January 1, 2008, to December 31, 2015. Patients were followed from the date of discharge
(time zero) to December 31, 2016 (end of study) or death. The study was conducted in the region
of Valencia in Spain (around 5 million inhabitants, representing 10% of the whole country pop-
ulation) providing free, universal health care services (besides drug cost-sharing) to 97% of the
region’s population. Data were obtained from the Valencia Health System Integrated Database
(VID). The VID is the result of the linkage, by means of a single personal identification number,
of a set of publicly owned population-wide health care, clinical, and administrative electronic
databases in the region of Valencia, Spain, which has provided comprehensive information
since 2008 (Garcia et al. IJE., 2020).
From 34491 patients discharged alive after hip fracture, 25807 (74.8%) were women and
8684 (25.2%) men. Regarding age, 12.4% of patients were under 75 years old, 43.6% were
between 75 and 85 years old, 40.6% were between 85 and 94 years old, and 3.4% were over 95
years old. The mean age at the first fracture was 83.4 years (IQR: 79.0-88.3). Patients were
followed a median time of 5.0 years (IQR: 3.0-7.0 years).
The estimation of the incidence of recurrent hip fractures and death after an osteoporotic hip
fracture, one of the main objectives of the study, could be approached by means of a competing
risk model when the refracture condition is considered as a terminal event which competes
with the risk of death or as an illness-death multi-state model in the case that the refrac-
ture condition can be considered as a transitory state towards death. Figure 3 shows both
approaches.
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Figure 3: Competing risks model with recurrent hip fracture and death as causes of failure
(left panel). Illness-death model with an initial state of hip fracture, a recurrent hip fracture
state and a death state (right panel).
We started by working with a competing risk model with two possible causes of failure,
recurrent fracture (R) and death (D) from the initial state discharge after fracture (F ) and
as relevant survival times the time from discharge after fracture to refracture, TFR, and time
from discharge after fracture to death, TFD. Later on we discussed an illness-death model with
the same three states as in the competing model but allowing the access to death from the
refracture state and the subsequent time from refracture to death, TRD (See Figure 3). The
latter model has a structure much closer to the reality of the problem than the one proposed
by the competing risks framework. The number of patients in each transition (F to R, F to D,
and R to D) for women and men is shown in Figure 5 of supplementary material.
3.2 Bayesian modeling
Cox proportional hazards models are very popular regression models (Cox, 1972). They express
the hazard function of the survival time of interest in terms of a baseline hazard function,
which determines the temporal shape of the hazard, and an exponential term which includes
the relevant covariates. Cox proportional hazards models with Weibull baseline hazard func-
tions, and gender and age at discharge as covariates have been used to model the random
behaviour of times TFR and TFD in the competitive risk model and of times TFR, TFD, and TRD
in the multi-state model in terms of the hazard functions as follows:
COMPETING RISKS MODEL:
hFR(t) =h0,FR(t) exp{β(FR)1 IWoman + β
(FR)
2 Age},
hFD(t) =h0,FD(t) exp{β(FD)1 IWoman + β
(FD)
2 Age}
where IWoman is an indicator variable that takes the value 1 when the individual is con-
sidered as a woman and zero if he is registered as a man. h0,FR(t) and h0,FD(t) is the
baseline hazard function for TFR and TFD, respectively, which we define below as
h0,FR(t) = α
(FR)λ(FR)tα
(FR)−1; h0,FD(t) = α
(FD)λ(FD)tα
(FD)−1, (8)






2 ) the regression coefficients associated to sex and age, re-
spectively, for time TFR (TFD).
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ILLNESS-DEATH MODEL:
The definition of the hazard functions for the survival times in the the illness-death model
were analogous to the ones for the competing risk model. The common transitions, i.e
from state F to R and from F to D, were modelled identically. However, transition from
refracture to death required to be modelled with consideration to the time when patients
refractured as follows
hRD(t− tFR | TFR = tFR) = h0,RD(t− tFR | TFR = tFR) exp{β(RD)1 IWoman +β
(RD)
2 Age}, (9)
for 0 < tFR < t, where h0,FD(t | TFR = tFR) is the baseline hazard function and β(RD)1 , β
(RD)
2
are the regression coefficients associated to sex and age, respectively. The baseline hazard
function was defined as
h0,RD(t− tFR | TFR = tFR) = α(RD)λ(RD)(t− tFR)α
(RD)−1. (10)
Note that although we modelled the common transitions in the competing risk model and
the illness-death model identically, they are different models. Despite the fact that the
common parameters have the same names, they are not equal because of their distinct
provenance.
We used a Bayesian approach to estimate the parameters of both models. We have followed
the usual steps of the Bayesian inferential process: specification of a prior distribution for
the parameters of the model, construction of the likelihood function, and computation of the
posterior distribution via Bayes’ theorem.
The prior distribution is elicited assuming a prior independence and non-informative sce-
nario. Wide normal prior distributions were selected for the regression coefficients, β, and
Gamma distributions for the shape and scale parameters α and λ (See Alvares et al., (2021)
for a wide tutorial on Bayesian survival models). Posterior distributions were approximated
via Markov Chain Monte Carlo methods (MCMC) as well as through the integrated nested
Laplace approximation (INLA). The former are simulation procedures very used in Bayesian
statistics for dealing with non analytical posterior distributions (Chen, Shao, and Ibrahim,
2000). The latter method computes approximations of the posterior marginals for the parame-
ters and hyperparameters in latent Gaussian models, a subset of models which includes gener-
alized regression models, smoothing splines models, spatial and survival models, among others
(Rue, Martino and Chopin, 2009). In particular, age as a covariate is included in the model as
mean-centered in order to improve the convergence of the subsequent computational Markov
chain Monte Carlo methods used.
3.3 Results
Posterior distribution
The approximate posterior distribution of the competing risk and of the illness-death model
parameters have been summarized in Table 1 via their posterior mean and standard devia-
tion. No differences have been observed between the results of the competing risk and the
illness-death model for the two common transitions, from fracture to refracture and from frac-
ture to death. However, the illness-death model provides additional information regarding the
transition from refracture to death.
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Competing risks model Illness-death model
Transition Parameter Mean SD Mean SD
From F to R α(FR) 0.9197 0.0156 0.9198 0.0157
λ(FR) 0.0279 0.0013 0.0279 0.0013
β
(FR)
1 0.0254 0.0496 0.0262 0.0486
β
(FR)
2 0.0244 0.0030 0.0244 0.0030
From F to D α(FD) 0.7759 0.0051 0.7759 0.0051
λ(FD) 0.3310 0.0051 0.3311 0.0050
β
(FD)
1 -0.5088 0.0169 -0.5092 0.0166
β
(FD)
2 0.0705 0.0012 0.0705 0.0012








Table 1: Summary of the posterior distribution of the parameters for the competing risks model
and of the illness-death model.
Refracture and death
The cumulative incidence function for refracture (death) assesses the probability that a person
refractures (dies) before a certain time. These probabilities depend on the parameters of the
model and consequently their posterior distribution is determined by the posterior distribution
computed previously. Competing risk and illness-death models provide almost identical results
for the incidence of refracture and death without refracture (See Table 2, posterior mean of
the one-year cumulative incidence of refracture and death from any cause by sex and age).
However, the illness-death model provides additional information regarding the probability of
transition from refracture to death (or the cumulative incidence of death after refracture).
Overall, refracture probability increases with age and women have also higher incidence
(one-year incidences of 1.96% at 70 and 2.80% at 90 years old for women, whilst 1.86% and
2.46% for men). Regarding death without refracture, incidence increases with age and has
been estimated higher for men (one-year incidences of 7.36% at 70 and 26.73% at 90 years old
among women, versus 11.94% and 40.34% for men).
Death after refracture
The illness-death model provides relevant information about the transition from refracture
to death that the competing risks model cannot address. Figure 4 shows the posterior mean
of the cumulative incidence of refracture and the posterior mean of the transition probability
from the initial state of fracture to the refracture state. Both outcomes are defined in relation
to a specific time t. The upper curve corresponds to the total accumulation of refractures
(cumulative incidence) occurred before time t and the lower curve refers to the probability
that a patient is in the state of refracture at time t, and therefore alive. Thus, it should be
understood that at time t the dark shaded area shows living patients who have refractured
and the light shaded area shows refractured patients who have died.
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Competing risks model Illness-death model
Transition Sex Age Mean 95% CI Mean 95% CI
From F to R
Women 70 1.96 (1.76, 2.16) 1.96 (1.76, 2.16)
80 2.39 (2.23, 2.55) 2.39 (2.24, 2.55)
90 2.80 (2.61, 2.99) 2.80 (2.60, 3.00)
Men 70 1.86 (1.65, 2.08) 1.86 (1.65, 2.09)
80 2.21 (2.01, 2.42) 2.21 (2.01, 2.42)
90 2.46 (2.21, 2.72) 2.45 (2.21, 2.72)
From F to D
Women 70 7.36 (7.07, 7.68) 7.36 (7.05, 7.67)
80 14.30 (13.96, 14.65) 14.30 (13.95, 14.63)
90 26.73 (26.20, 27.27) 26.72 (26.17, 27.26)
Men 70 11.94 (11.43, 12.46) 11.95 (11.43, 12.46 )
80 22.63 (21.99, 23.28) 22.63 (22.02, 23.29)
90 40.34 (39.33, 41.36) 40.35 (39.42, 41.36)
From R to D
Women 70 14.77 (12.73, 16.87)
80 23.11 (21.52, 24.79)
90 35.14 (32.75, 37.60)
Men 70 25.56 (22.01, 29.37)
80 38.46 (35.25, 41.87)
90 55.03 (50.61, 59.59)
Table 2: Posterior mean and 0.95 credibility interval of the one-year cumulative incidences of
refracture, death without refracture and death after refracture for the competing risks model
and for the illness-death model, by sex and age.
In broad terms, death after refracture shows a similar pattern to death without refracture,
i.e incidence increases with age and is higher for men (one-year incidences of 14.77% at 70 and
35.14% at 90 years old for women, whereas 25.56% and 55.03% for men).
4 Concluding remarks
Several authors have addressed the relation between competing risks and multi-state models,
with consensus on identifying the first as a particularization of the second (Andersen, 2002;
Putter, 2007). Moreover, some authors performed comparisons between both model estima-
tions (Leffondré, 2013). However, there is no literature available comparing both estimations
from a Bayesian perspective. In this paper, we showed that not only can the competing risks
model be considered as a particular case of an illness-death model, but also they provide iden-
tical information of the common transitions under some given conditions. It is a matter of prior
independence of the parameters and separability of the likelihood. Regarding likelihood from
both models, it presents a separated structure, with separated products for each transition.
It results in a sort of “independent” transitions, what makes the inclusion of a new transition
after refracture not to change the estimations of the other transitions. Had transitions had
shared parameters, estimations might have differed. Correlated random effects would be also
supposed to violate the separability, resulting in different estimations from a competing risks
and an illness-death model. Finally, non-informative and independent priors were assumed for
10
Figure 4: Posterior mean of the cumulative incidence of refracture (upper curve) and of the
transition probability from initial state to refracture state (lower curve). Light area in both
figures represents the proportion of dead patients who had previously suffered a refracture
while the dark area represents the proportion of refractured people still alive.
the parameters. Prior correlation between parameters might translate into posterior correla-
tion and thus posterior distributions would be sensitive to the addition of new transitions.
An important consideration should be made about the estimation of the incidence of death
among the population. Although the incidence of refracture can be estimated equally from
both of our models, it is not the case with the incidence of death. The proposed competing
risks model only accounts for death without refracture, as the observation of death is censored
for those refractured patients. However, when including death after refracture through the
illness-death model, the total incidence of death becomes a natural outcome. In particular, it is
defined as the transition probability from the initial state at the beginning of the follow-up time
to death state. This advantage, always under the aforementioned assumptions and considera-
tions, makes the illness-death model a preferable tool/method to assess cumulative incidences
when studying more than one event or when death is an unavoidable event to consider (e.g.
elder population).
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Figure 5: Number of patients in each transition by sex.
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